EPISODE · Mar 12, 2021 · 30 MIN
Biotech SPACs: A new route to going public
As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies access public markets long-term? Our investment banking team goes inside the SPAC boom to explain what companies need to know before choosing their path to going public.
Embed this episode
NOW PLAYING
Biotech SPACs: A new route to going public
0:00
30:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 30 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on March 12, 2021.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!